Andrew Lo is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 48,099 shares of BBIO, which is worth approximately $1.37 Million. The most recent transaction as insider was on Dec 30, 2021, when has been sold 1,500 shares (Common Stock) at a price of $14.3 per share, resulting in proceeds of $21,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.1K
0% 3M change
0% 12M change
Total Value Held $1.37 Million

Andrew Lo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 30 2021
BUY
Open market or private purchase
$21,450 $14.3 p/Share
1,500 Added 3.02%
48,099 Common Stock
Dec 29 2021
BUY
Open market or private purchase
$77,400 $12.9 p/Share
6,000 Added 11.41%
46,599 Common Stock

Also insider at

ABCL
AbCellera Biologics Inc. Healthcare
ROIV
Roivant Sciences Ltd. Healthcare
AL

Andrew Lo

London, X0

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO